Year: 2026
Type: editorial
Abstract: biomarkers of treatment response could further refine patient stratification and help identifying patients with refractory disease who might benefit from rapid therapeutic escalation.
Source: Blood
Author: Daisuke Nakada
Institution: Baylor College of Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7128701048